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A diverse array of external stimuli, including most hormones
and neurotransmitters, bind to cell surface receptors that acti-
vate G proteins. Mating pheromones in yeast Saccharomyces
cerevisiae activate G protein-coupled receptors and initiate
events leading to cell cycle arrest inG1phase.Here,we show that
the G subunit (Gpa1) is phosphorylated and ubiquitinated in
response to changes in the cell cycle.We systematically screened
109 gene deletion strains representing the non-essential yeast
kinome and identified a single kinase gene, ELM1, as necessary
and sufficient for Gpa1 phosphorylation. Elm1 is expressed in a
cell cycle-dependent manner, primarily at S and G2/M. Accord-
ingly, phosphorylation of Gpa1 in G2/M phase leads to poly-
ubiquitination in G1 phase. These findings demonstrate that
Gpa1 is dynamically regulated.More broadly, they reveal howG
proteins can simultaneously regulate, and become regulated by,
progression through the cell cycle.
G protein coupled receptors and heterotrimeric G proteins
are the predominant components through which cells receive
and transduce extracellular signals. G protein signal transduc-
tion is highly conserved throughout eukaryotes, including the
yeast Saccharomyces cerevisiae. In yeast, haploid a-type cells
secrete an a-factor pheromone that binds to receptors on the
surface of -type cells, whereas -type cells secrete an -factor
that acts exclusively on a-type cells (1). Consequently, the hap-
loid cells fuse to form an a/ diploid cell.
As with otherG protein systems, activation of the yeast pher-
omone receptor stimulates exchange of GDP for GTP on the G
protein  subunit (Gpa1),2 which promotes its dissociation
from the G (Ste4/18) heterodimer (1, 2). In yeast, G is
primarily responsible for transmission and amplification of the
signal to effector proteins, whereas the G subunit serves pri-
marily to regulate the levels of freeG. As a consequence, cells
are highly sensitive to small changes in the stoichiometry of G
and G (3–5). The signal is terminated by hydrolysis of GTP
toGDPon theG subunit, which promotes reassociation of the
heterotrimeric G protein complex. Further regulation is
imposed by accelerating the GTPase activity of G via regula-
tors of G protein signaling proteins (6).
Propagation of theG protein signal requires components of a
MAPK cascade (Ste20, Ste11, Ste7, Fus3, or Kss1), a MAPK
scaffold (Ste5), as well as a transcription factor (Ste12) (1). Con-
sequently, the pheromone initiates changes in gene expression
and cell morphology that prepare the cell to undergo cell-cell
and nuclear fusion. Critical to this process is the initiation of
cell cycle arrest in G1 phase, which ensures that each haploid
cell contains exactly one copy of every chromosome before
fusion (7). Pheromone-induced G1 arrest necessarily prevents
fusion during DNA replication (S phase) or before mitosis (M
phase), during which nuclear fusion could lead to missegrega-
tion of geneticmaterial, aneuploidy, and other proliferative dis-
advantages (8, 9). Consequently, yeast mating and cell cycle
progression must be highly coordinated processes.
The mating pathway is well known to regulate the cell cycle
by stimulating expression of Far1, a cyclin-dependent kinase
inhibitor that arrests cells at START in late G1 phase (10–14).
Reciprocally, Far1 is itself regulated in a cell cycle-dependent
manner and is degraded after cells pass through START and
exit G1 phase (10, 11). Degradation of Far1 is initiated in G1 by
cyclin-dependent kinase-mediated phosphorylation, which
promotes its ubiquitination by the SCF (Skp1/Cullin/F-box)
ubiquitin ligase (13, 15, 16).
Emerging evidence suggests that multiple mating pathway
components are regulated by ubiquitination. Targets of ubiquitin-
mediated degradation include the regulator of G protein signaling
protein Sst2 (17), theMAPK kinase Ste7 (18), theMAPK scaffold
protein Ste5 (19), and the G protein  subunit Gpa1 (20–23). Of
these, the SCF has been shown to be necessary and sufficient for
ubiquitination of Gpa1 (4). While SCF substrates are generally
phosphorylated prior to ubiquitination (24, 25), as yet the kinase
that phosphorylates Gpa1 has not been identified.
Here we identify a novel G protein kinase, Elm1. We show
that the G protein is phosphorylated directly by Elm1 and that
phosphorylation occurs in coordination with Elm1 expression
during the cell cycle. G protein phosphorylation in G2/M phase
leads to ubiquitination during the following G1 phase. In the
absence of Elm1, the G protein is neither phosphorylated nor
ubiquitinated. Taken together, these findings show howG pro-
teins can simultaneously regulate, and become regulated by,
progression through the cell cycle.
EXPERIMENTAL PROCEDURES
Strains and Plasmids—Standard methods for growth, main-
tenance, and transformation of yeast and bacteria were used
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throughout. To ensure accurate cell density comparisons, a
diluted fraction of each cell culture was lightly sonicated before
measurement at an A600 nm to break apart cell clusters that
commonly form between elm1 cells. Strains used in this study
were BY4741 (MATa leu2 met15 his3 ura3), elm1
(BY4741 elm1::KanMX4), ELM1-TAP (Yeast TAP-fusion
library, Open Biosystems), cdc6-1 (BY4741 cdc6-1 hph) (pro-
vided by Jean Cook, University of North Carolina), 15Dau
(MATa ade1 his2 leu2–3, trp1–112, ura3), cdc28-1 (15Dau,
cdc28-1) (provided by Beverly Errede, University of North Car-
olina), LHY488 (MATa his3-200 leu21 ura3–52 lys2–801
trp163 ade2–101), LHY489 (LHY488 cim3-1) (provided by
Linda Hicke, Northwestern University) (26), MTY235 (MATa
ade2-1 his3–11,15 leu2–3,112 trp1-1 ura3-1 can1–100),
MTY670 (MTY235 cdc34-2), and MTY668 (MTY235 cdc4-1)
(provided by Mike Tyers, Samuel Lunenfield Research Insti-
tute) (27). Integrated yeast strains were constructed by plasmid
integration of pRS406-GPA1-(81-1539 bp) or pRS406-GPA1-(81-
1539 bp)S200A at the naturally occurring HindIII site within
GPA1, resulting in a single full-length copy of GPA1 at its
endogenous locus. Integration was validated by immunoblot-
ting with wild-type cells to confirm loss of the phosphorylation
dependent mobility shift (in the case of S200A). All experiments
were done in BY4741 unless otherwise specified. Table of yeast
strains used in this study are shown in supplemental Table 1.
Plasmid Construction—Yeast shuttle plasmids pRS315-
ELM1 and pRS316-ELM1 were constructed by PCR amplifica-
tion of ELM1  500 bp flanking the open reading frame (prim-
ers SalI-ELM1-F and SacI-ELM1-R) and directional cloning
into the SalI and SacI sites of pRS315 or pRS316. Single point
mutations (Gpa1S200A, Gpa1S200E, and Elm1K117R) were con-
structed by QuikChange (Stratagene) mutagenesis using the
indicated primers (supplemental Table 2). Plasmids containing
gpa115S/T-A were constructed by chemical synthesis of a 413-bp
fragment of GPA1 (base pairs 392–786 of the open reading
frame starting from the naturally occurring HindIII restriction
site of GPA1) within which all serine and threonine codons
were mutated to alanine, and a silent BglII site was introduced
bymutation of base pairs 781 and 783 (GenScript). The synthe-
sized fragment was cloned into GPA1 plasmids in which the
same silent BglII mutation was introduced by QuikChange
(using primer GPA1-BglII-F/R), followed by restriction diges-
tion with HindIII and BglII. pYEX 4T-1-GST-ELM1 was puri-
fied from the yeast GST-fusion library host strain EJ 758 (28)
using a yeast plasmid miniprep kit (Zymo Research) and then
retransformed into BY4741 elm1 cells for expression of GST-
Elm1. All plasmids were verified by DNA sequencing.
Growth Arrest and Release—Log-phase cell cultures were
arrested in G1 phase with a synthetic -factor peptide (30 M
final concentration, CHI Scientific 53424), in S phase by addi-
tion of hydroxyurea (added in powder form to 10 mg/ml final
concentration, Sigma Aldrich H8627), and in G2/M phase by
addition of nocodazole (15 g/ml final concentration, Sigma
Aldrich M1404). Note that for G2/M phase arrest, cells were
first treated with 1% dimethyl sulfoxide for 30 min at 30 °C,
followed by addition of nocodazole (100 stock at 1.5mg/ml in
dimethyl sulfoxide), resulting in a 2% final concentration of
dimethyl sulfoxide in the cell culture. Each arrestwas allowed to
proceed for 2.5 h at 30 °C unless otherwise noted. Cells were
released from arrest by centrifugation and washing with 3 
100 ml of sterile water followed by resuspension in fresh
medium to an A600 nm of 0.7 and growth at 30 °C.
Growth of Temperature-sensitive Mutants—Temperature-
sensitive mutants (cdc6-1, cdc28-1, cdc4-1, or cdc34-2) and the
isogenic wild type counterstrains were grown at a permissive
temperature (25 °C) to early log-phase and then shifted to
the restrictive temperature (37 °C) for 2.5 h to induce cell cycle
arrest in G1 phase (cdc28-1 cells), or early S phase (cdc6-1 cells)
and for 1 h to inactivate the SCF ubiquitin ligase (cdc4-1 or
cdc34-2 cells).
In Vivo Ubiquitination Assays—Gpa1 polyubiquitination
was detected by constitutive (ADH1 promoter) expression of
Gpa1 in yeast harboring a temperature-sensitive proteasome
mutation (cim3-1) or by coexpression of Gpa1 and Myc-ubiq-
uitin as described previously (22). For cim3-1 and isogenic wild
type cells, log-phase cultureswere grown at the permissive tem-
perature (25 °C) to anA600 nm of 0.5–0.6, followed by transition
to the restrictive temperature (37 °C) for 3 h. Inducible Myc-
ubiquitin strains were grown at 30 °C to an A600 nm of 0.5–0.6,
followed by addition of CuSO4 to 100 M for 3 h at 30 °C as
described previously (29). Detection of Gpa1 ubiquitination at
different cell cycle stages was accomplished by arresting log-
phase cells followed by induction of Myc-ubiquitin expression
for 3 h.
Protein Detection—Unless otherwise noted, cell pellets were
harvested by addition of 100% trichloroacetic acid (5% final
concentration), centrifugation at 4000  g for 1 min, washing
with 1ml of 10mMNaN3, and then stored as a frozen cell pellet
at80 °C. Protein extracts were generated by glass bead lysis in
trichloroacetic acid as described previously (30) and resolved by
10% SDS-PAGE and immunoblotting. Membranes were
probed with anti-Gpa1 at 1:1000 (31), anti-FLAG at 1:1000
(F1804, SigmaAldrich), anti-Clb2 at 1:350 (sc-9071, Santa Cruz
Biotechnology), anti-p44/42 at 1:500 (9101L, Cell Signaling
Technology), anti-Kss1 at 1:350 (sc-6775, Santa Cruz Biotech-
nology), anti-Fus3 at 1:350 (sc-6773, Santa Cruz Biotechnol-
ogy), anti-G6PDH at 1:50,000 (A9521, Sigma Aldrich), anti-
Myc at 1:100 (9E10 mouse monoclonal antibody), and
anti-protein A at 1:50,000 (P3775, Sigma Aldrich). Immunore-
active species were visualized by chemiluminescent detection
(PerkinElmer Life Sciences) of horseradish peroxidase-conju-
gated anti-rabbit (170-5046) or anti-mouse IgG (170-5047)
(Bio-Rad). Where indicated, image densitometry was con-
ducted usingNational Institutes ofHealth ImageJ software (32).
Statistical analysis was conducted usingGraphPad Prism 4 for a
minimum of three independent experiments unless noted
otherwise.
Phosphatase Assays—Cells grown to an A600 nm of 1.0 were
harvested by centrifugation at 2000  g and stored at 80 °C.
Cell pellets were resuspended in 1  phosphatase buffer (New
England Biolabs) containing 50 mM HEPES (pH 7.5), 100 mM
NaCl, 2 mM DTT, 0.01% Brij 35, 1 mM MnCl2, and 1 EDTA-
free protease inhibitors (Roche). Each resuspended pellet was
split in half and subjected to glass bead lysis in the presence or
absence of phosphatase inhibitors (50 mM NaF and 1.3 mM
sodium orthovanadate) (S6508, Sigma Aldrich). Lysates were
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centrifuged at 21,000  g for 15 min, and the supernatant frac-
tion was then collected into a fresh tube with or without 60
units (2.25 units/l final concentration) of  protein phospha-
tase (New England Biolabs) for 30 min at 30 °C. The reaction
was stopped by addition of 6 SDS-PAGE loading buffer, and
the samples were immediately subjected to SDS-PAGE and
immunoblot analysis. Alternatively, phosphatase assays were
conducted on purified protein. Briefly, 1 l of yeast-purified
Gpa1-FLAG was diluted in 1 -phosphatase buffer with or
without 20 units (2 units/l final concentration)  protein
phosphatase.
GST-Elm1 Expression, Purification, and in Vitro Kinase
Assay—1 liter cultures of elm1 cells harboring pYEX-4T1-
GST-ELM1 or elm1K117R were grown to an A600 nm of 0.7 and
treated with 500 M CuSO4 for 2 h to induce expression of
GST-Elm1. Cells were harvested, washed with water, and
stored at 80 °C. The cell pellets were subjected to glass bead
lysis in buffer containing 20 mM Tris-HCl (pH 8.0), 400 mM
NaCl, 2 mM MgCl2, 5% glycerol, 0.1% Triton X-100 (Sigma
Aldrich), 1mMDTT, 1protease inhibitormixture tablets, and
500 M PMSF. The lysate mixture was subjected to microcen-
trifugation at 21,000  g for 10 min, and GST-Elm1 was puri-
fied from the soluble extract using glutathione-SepharoseTM 4
Fast-flow (GE Healthcare) followed by washing with buffer
containing 20 mM Tris-HCl (pH 8.0), 400 mM NaCl, 2 mM
MgCl2, 5% glycerol, and 1 mM DTT and elution with dialysis
buffer containing 20 mM glutathione (pH 7.5). Eluted protein
was dialyzed with a slide-a-lyzer mini cartridge (Pierce) into
kinase storage buffer containing 20 mM Tris-HCl (pH 8.0), 100
mM NaCl, 2 mM MgCl2, and 5% glycerol. In vitro kinase assays
were conducted by incubating 0.08–0.16 pmol of purified
GST-Elm1 (3.2–6.4 nM final concentration) and 12.5–25 pmol
of recombinant purified Gpa1 or indicated mutants (0.5–1 M
final concentration) in 1 kinase reaction buffer previously
described for in vitro Elm1 kinase assays and containing 50 mM
Tris-HCl (pH 7.5), 10 mMMgCl2, 5 mMDTT, 2 mM EGTA, 200
mM sodium orthovanadate, and 10 Ci of [-32P]ATP
(PerkinElmer Life Sciences) for 1 h at 30 °C (33). Reactionswere
stopped by addition of 6 SDS-PAGE loading buffer and
immediately subjected to SDS-PAGE. The resulting gel was
dehydrated and exposed to autoradiography film (HyBlot CL,
Denville Scientific).
Affinity Purification of Gpa1-FLAG—Yeast harboring
pRS316-ADH-GPA1-FLAG was grown to early log-phase and
then harvested by centrifugation. The resulting cell pellet was
lysed, andGpa1-FLAGwas purified as described previously (4).
Gene Transcription Assay—Pheromone-dependent tran-
scription reporter assays were conducted as described previ-
ously (34). Briefly, cell cultures at an A600 nm of 0.8 were dis-
pensed (90l into each of 48 wells of a 96-well plate) andmixed
with 10l of-factor peptide at the indicated concentration for
90 min at 30 °C. Next, each well was mixed with 20 l of FDG
solution (130 mM PIPES (pH 7.2), 0.25% Triton-X100, 0.5 mM
fluorescein di--galactopyranoside (Marker Gene Technolo-
gies, M0250)) for 1 h at 37 °C. The reaction was stopped by the
addition of 20 l of 1 M sodium bicarbonate followed by fluo-
rescence quantification using a fluorescence plate reader (Spec-
traMax M5, Molecular Devices).
Escherichia coli Expression of His6 Fusion Proteins—Recom-
binant His6-Gpa1 was expressed by autoinduction as described
previously (35). All procedures were conducted at 4 °C unless
noted otherwise. Briefly, competent BL21-RIPL cells (Strat-
agene) were transformed with the indicated expression vector.
5 ml of saturated starter cultures (containing ZY medium (10
g/l tryptone, 5 g/l yeast extract) with 15mg of glucose, 50g/ml
carbenicillin, 25 g/ml chloramphenicol) were used to inocu-
late 800 ml of ZY medium containing 1 M solution (25 mM
Na2HPO4, 25 mM KH2PO4, 50 mM NH4Cl, 5 mM Na2SO4), 1
5052 solution (0.5% (w/v) glycerol, 0.5% (w/v) glucose, 10%
(w/v) -lactose), 50 mMMgSO4, 50 g/ml carbenicillin, and 25
g/ml chloramphenicol. Cultures were grown for 8 h at 37 °C
and then shifted to 18 °C overnight. The G protein was puri-
fied by nickel-affinity chromatography as described previ-
ously (23) but without cleavage of the N-terminal His6 tag.
The resultant protein was dialyzed by slide-a-lyzer (Pierce)
in 20 mM Tris (pH 8.0), 100 mM NaCl, 2 mM MgCl2, 20 M
GDP, and 0.5 mM tris(2-carboxyethyl)phosphine.
RESULTS
Gpa1 Is a Phosphoprotein—Gpa1undergoes a variety of post-
translational modifications, including myristoylation, palmi-
toylation, and ubiquitination (21, 36). The myristoylation state
of Gpa1 can be distinguished by an electrophoretic mobility
shift following SDS-PAGE and immunoblotting. Because only a
fraction of Gpa1 is mobility-shifted under these conditions, the
prevailing view has been that Gpa1 exists in bothmyristoylated
andnon-myristoylated states (37).However, upon close inspec-
tion of overexpressed protein, we found that even non-myris-
toylated Gpa1G2A exhibits differential mobility by immuno-
blotting, indicating the presence of another modification (Fig.
1A). Given that phosphorylation can likewise alter the electro-
phoretic mobility of proteins, we asked whether phosphoryla-
tion rather than myristoylation might account for the second
form of Gpa1. Consistent with this hypothesis, phosphatase
treatment of whole cell extracts (Fig. 1B) or of purifiedGpa1 (C)
resulted in complete loss of the slower migrating form of Gpa1.
We also found thatmutation of serine 200, whichwas identified
as a phosphorylation site bymass spectrometry (38), altered the
mobility of Gpa1. Substitution of Ser-200 with alanine (S200A)
FIGURE 1. Phosphorylation induces an electrophoretic mobility shift in
Gpa1. Immunoblot analysis of Gpa1 using Gpa1-specific antibodies. A, cells
over-expressing wild-type GPA1 (pAD4M-GPA1) (WT) or the myristoylation-
site mutant GPA1G2A (G2A) analyzed by immunoblotting. The arrow marks the
position of the presumptive phosphorylated form of Gpa1. B, soluble protein
extracts from cells overexpressing wild-type Gpa1 were split into two sepa-
rate aliquots, and one half was treated () with -protein phosphatase.
p-Gpa1, phosphorylated Gpa1. C, Gpa1-FLAG purified from nocodazole-ar-
rested cells and treated () with -protein phosphatase (ppase). D, wild type
cells overexpressing wild-type Gpa1 (WT) or phosphorylation site mutants
(S200A, ALA or S200E, GLU). *, nonspecific immunoblot band.
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or glutamate (S200E) replicated the mobility of dephosphory-
lated and phosphorylatedGpa1, respectively (Fig. 1D).We con-
clude that Gpa1 is a phosphorylated protein.
A Yeast Kinome Screen Reveals Elm1 as a G Protein Kinase—
To identify the Gpa1 kinase, we monitored the phosphoryla-
tion-dependent mobility shift of endogenously expressed Gpa1
in gene deletion strains representing the majority of the yeast
kinome. Of the 109 strains tested, deletion of ELM1 alone
resulted in a significant observable loss of phosphorylated
Gpa1. Phosphorylation of Gpa1 was restored by plasmid-borne
expression of ELM1 (Fig. 2A).We observed no such differences
in the absence of kinases that act downstream of Elm1 or that
are functionally similar to Elm1 (see discussion, supplemental
Fig. 1A) (33, 39). In addition to testing kinase deletions, we also
monitored Gpa1 phosphorylation in each of 31 phosphatase-
deletion strains, including all those involved in the pheromone
response, but did not observe any difference in the abundance
of phosphorylated Gpa1 (supplemental Fig. 1C). We conclude
that Elm1 phosphorylates Gpa1 in vivo.
Elm1 Is Required for Maximal Pheromone-induced Gene
Transcription—Elm1 is best known as a regulator of cell mor-
phology during G2/M phase of the cell cycle. During G2/M,
Elm1 phosphorylates proteins required for the morphogenesis
checkpoint that coordinates bud emergence and mitosis (40,
41) as well as for organization of septins during cytokinesis (33,
39, 42). Yeast harboring elm1mutations exhibit a morphologi-
cally distinct growth pattern in which cells delay cytokinesis
and undergo elongated bud growth, a process that also occurs
under conditions of nitrogen starvation and filament-
ous growth (43). Elm1has been proposed to inhibit the filamen-
tous growth response that includes multiple signaling pathway
branches, including (but not limited to) theMAP kinases Ste20,
Ste11, Ste7, and Kss1 (43, 44), all of which participate as well in
the pheromone response pathway. Accordingly, we found that
Kss1 was more highly expressed and activated in elm1 com-
pared with wild-type cells (Fig. 2B). In addition, deletion of
KSS1 in elm1 cells reduced the filamentous-like phenotype
(elongated buds and flocculation) typical of elm1 cells (Fig.
2C). In contrast, the other pheromone-responsiveMAP kinase,
Fus3, was largely unaffected by the absence of Elm1 (Fig. 2B).
We next determined whether Elm1 regulates pheromone-
dependent gene transcription using a -galactosidase reporter
fused with the promoter of the mating-specific gene FUS1. We
found that elm1 cells exhibit a significantly reduced maxi-
mum level of pheromone-induced gene transcription. Signal-
ing was restored upon plasmid-borne expression of wild-type
Elm1 but not kinase-inactive Elm1K117R (Fig. 2D). Thus, Elm1
represses activation of the MAP kinase branch of the filamen-
tous growth response, including Kss1, and is required for max-
imum response to the pheromone.
Gpa1 Is PhosphorylatedDirectly by Elm1—Elm1 clearly plays
a role inmultiple signaling pathways, including the filamentous
FIGURE 2. Yeast kinome screen reveals Elm1 as a Gpa1 kinase. The abundance of phosphorylated Gpa1 was determined by immunoblotting 109 different
kinase gene deletion strains. A single kinase, Elm1, is required for detection of phosphorylated Gpa1. A, validation of kinome screen results. Wild-type cells (WT)
or cells expressing GPA1S200A (by gene replacement) or elm1 cells harboring empty vector or plasmid-borne ELM1 (ELM1). B, analysis of pheromone-depen-
dent () MAP kinase activation (top panels, different exposures) and total expression (bottom panels) in WT, elm1, and elm1 kss1 cells. IB, immunoblot.
C, differential interference contrast (DIC) images of yeast strains used in the pheromone signaling assays shown in B and D. D, analysis of pheromone-depen-
dent gene transcription in elm1 cells with the indicated plasmid containing ELM1, elm1K117R, or an empty vector (EV). Indicated are yeast strains expressing a
FUS1-lacZ reporter treated with the indicated concentrations of mating pheromone. Results show the mean  S.E. for four individual experiments, each
performed in quadruplicate. RFU, relative fluorescence units.
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growth and pheromone response pathways, any of which could
be indirectly responsible for the diminished Gpa1 phosphory-
lation in elm1 cells. Therefore, we asked whether Elm1 acts
directly onGpa1.We established that purified Elm1 can bind to
and phosphorylate recombinant Gpa1 in vitro (Fig. 3). Elm1 is
capable of autophosphorylation (43), and we show that this
activity is exhibited as well by GST-Elm1 (Fig. 3, A–C). Both
Elm1 autophosphorylation and Gpa1 transphosphorylation
were blocked when catalytically inactive GST-Elm1K117R was
substituted for the wild-type kinase (Fig. 3A). Consistent with
our findings in vivo, Ser-200 is required formaximumphosphor-
ylation of Gpa1 (Fig. 3B). Similar results were observed upon
mutation of all 15 Ser and Thr residues in the ubiquitination
domain (data not shown). Finally, Elm1 was able to bind to, but
not effectively phosphorylate, Gpa1UD, amutant that lacks the
ubiquitination domain of the protein (residues 129–236) (Fig.
3, C and D). We conclude that Elm1 phosphorylates Gpa1
directly at Ser-200 and multiple other sites throughout the
protein.
Gpa1 Phosphorylation Is Cell Cycle-dependent—We next
determined how phosphorylation of Gpa1 is regulated. Elm1 is
expressed primarily during S and G2/M phases of the cell cycle
(42, 43, 45), a phenotype that we corroborated (supplemental
Fig. 2). Further, longstanding evidence indicates that themobil-
ity-shifted (phosphorylated) form of Gpa1 is significantly
reduced upon pheromone stimulation (31), which induces cell
cycle arrest in G1 phase. Thus, we considered whether Gpa1
phosphorylation is regulated during the cell cycle. We directly
compared Gpa1 from cells arrested in G1 phase with -factor
(-F), in S phase with hydroxyurea, or in G2/M phase with
nocodazole. Hydroxyurea inhibits deoxyribonucleotide syn-
thesis, inducing a DNA replication checkpoint arrest in S phase
(46). Nocodazole inhibits microtubule polymerization and
induces a checkpoint arrest at the metaphase/anaphase transi-
tion of mitosis (47). We found that phosphorylated Gpa1 is
most abundant in cells arrested in S andG2/Mphase but lowest
in cells arrested inG1 phase (Fig. 4A). To determine the dynam-
ics of phosphorylation during the cell cycle, wemonitoredGpa1
during arrest and release in cells treated with nocodazole or
hydroxyurea. To validate the arrest and release protocol, we
monitored changes in the mitotic cyclin Clb2 (48). We found
that phosphorylated Gpa1 accumulates in a coordinated fash-
ion with Clb2 as cells arrest in either G2/M or S phase (Fig. 4, B
and D). Upon release from nocodazole, phosphorylated Gpa1
FIGURE 3. Elm1 is necessary and sufficient for Gpa1 phosphorylation. The association between Elm1 and Gpa1 as determined by copurification and by in
vitro kinase assay. A, in vitro kinase assay with purified GST-Elm1 or catalytically inactive GST-Elm1K117R and purified recombinant Gpa1 in the presence of
[32P]ATP (left panel) and GST-Elm1 input detected by immunoblot with anti-GST (right panel). B, in vitro kinase assay with GST-Elm1 and purified recombinant
Gpa1 (WT), Gpa1S200A (S200A), or Gpa11-36,129-236 (UD) in the presence of [32P]ATP. Shown is the incorporation of radioactive phosphate (left panel)
and Gpa1 input detected by Coomassie staining (right panel). C, in vitro kinase assay with GST-Elm1 and with purified recombinant His6-tagged Gpa1 (WT),
Gpa11-36 (N), or Gpa11-36, 129-236 (UD) lacking the ubiquitinated subdomain. Shown is the incorporation of radioactive phosphate (left panel) and Gpa1 input
detected by Coomassie gel staining (right panel). D, in vitro affinity purification using nickel affinity matrix and immunodetection of bound GST-Elm1 described in C.
Relative 32P incorporation (Rel. p-Gpa1) is shown for Gpa1 and was calculated as follows: [32P signal/Coomassie signal]mutant/[
32P signal/Coomassie signal]WT.
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and Clb2 rapidly decrease in abundance and then increase con-
comitantly as cells reenter the cell cycle (Fig. 4C and supple-
mental Fig. 3). Similar coordination between phosphorylated
Gpa1 and Clb2 was evident in cells released from hydroxyurea-
induced cell cycle arrest (Fig. 4E). Finally, we observed temper-
ature-dependent accumulation of phosphorylated Gpa1 in
cdc6–1ts cells, which are incapable of DNA replication licens-
ing, resulting in a post-START arrest in late G1/early S phase
(Fig. 4A) (49, 50). We conclude that Gpa1 phosphorylation is
Elm1-dependent and cell cycle-regulated. Although phosphor-
ylated Gpa1 accumulates throughout the S and G2/M phases, it
is rapidly eliminated from cells during G1 phase.
Elm1 Is Required for Gpa1 Polyubiquitination—We have
shown previously that Gpa1 is polyubiquitinated by the
SCFCdc4 ubiquitin ligase (4) and that ubiquitination occurs pri-
marily at lysine 165 within the ubiquitinated subdomain of
Gpa1 (21). Typically, SCF recruits phosphorylated proteins as
substrates for ubiquitination (24, 25). Therefore, we asked
whether Elm1 phosphorylation promotes Gpa1 polyubiquiti-
nation.We compared Gpa1 polyubiquitination in the presence
and absence ofELM1 using a proteasome-deficient yeast strain,
cim3–1 (22, 23). For these experiments, Gpa1 was overex-
pressed to allow detection of the minor ubiquitinated species.
Growth of cim3–1 cells at the restrictive temperature inacti-
vates Cim3, an essential protein component of the 26 S protea-
some (51), thereby stabilizing polyubiquitinated proteins and
further enabling their detection by immunoblotting. Consis-
tent with the hypothesis, Gpa1 polyubiquitination is consider-
ably diminished in the absence of Elm1 or in the presence of
plasmid-borne Elm1K117R (Fig. 5). To validate the observations
made in cim3–1 cells, we also monitored Gpa1 polyubiquitina-
tion in wild-type or elm1 cells expressingmyc-ubiquitin (pro-
teins conjugated to myc-ubiquitin are degraded slowly) (sup-
plemental Fig. 4) (52, 53). Once again Gpa1 polyubiquitination
was diminished in the absence of Elm1.We conclude that Elm1
is required for ubiquitination, as well as for phosphorylation, of
Gpa1.
Gpa1 Ubiquitination Is Regulated during the Cell Cycle—
Phosphorylation is a well established precursor to ubiquitina-
tion by the SCF (25) and serves as a signal for recruitment of
target substrates by F-box proteins (54). Our previous findings
indicate that Gpa1 is ubiquitinated by SCFCdc4. The data pre-
sented above indicate that Gpa1 is phosphorylated by Elm1 and
that Elm1 is required for ubiquitination. Therefore, we postu-
lated that phosphorylation by Elm1 precedes ubiquitination by
SCF. To test this hypothesis, we compared the relative propor-
tion of phosphorylated Gpa1 in cells lacking functional Cdc4
(F-box protein) or Cdc34 (ubiquitin-conjugating enzyme),
FIGURE 4. Gpa1 phosphorylation is cell cycle-dependent. Cells treated for 2.5 h with -factor pheromone (-F, arrests cells in G1 phase), hydroxyurea (HU,
arrests cells in S phase) or nocodazole (NZ, arrests cells in G2/M phase) followed by release into fresh medium where indicated. Shown are aliquots taken at the
indicated time points followed by immunoblotting. The abundance of phosphorylated Gpa1 (black arrowhead) and Clb2 were quantified by densitometry from
the immunoblot shown above. AU, arbitrary units; AC, asynchronous cells; Load, G6PDH loading control. A, direct comparison of Gpa1 from arrested cells. Cells
were also arrested in late G1/early S phase by temperature shift of cdc6-1 cells. B, nocodazole arrest. C, nocodazole release. D, hydroxyurea arrest. E, hydroxyurea
release.
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which we previously identified as responsible for polyubiquiti-
nation of Gpa1 (4). Accordingly, we monitored Gpa1 in tem-
perature-sensitive cdc4-1 and cdc34-2mutants (27). Consistent
with the hypothesis, we found the proportion of phosphory-
lated Gpa1 to be higher in asynchronous cells lacking active
forms of either Cdc4 or Cdc34 but comparatively lower in iden-
tically treatedwild-type cells (Fig. 6A, left panel). Similar results
were obtained using Tet-repressible versions of CDC4 and
CDC34 (data not shown). Thus, phosphorylatedGpa1 accumu-
lates in the absence of functional SCFCdc4 ubiquitin ligase.
Finally, we considered whether ubiquitination, in addition to
phosphorylation, might be regulated by the cell cycle. In sup-
port of this model, accumulation of phosphorylated Gpa1 in
SCF-deficient cells is comparable with that observed in G2/M-
arrested cells (Fig. 6A, right panel). Moreover, we found that
Gpa1 polyubiquitination is significantly higher in cells arrested
inG1 phasewith-factormating pheromone or by temperature
inactivation of cdc28-1 when compared with cells arrested in S
phase or in G2/M phase (Fig. 6, B and C, and supplemental Fig.
5). Although treatment with -factor results in Far1-mediated
G1 arrest, cells expressing cdc28-1 undergo G1 arrest indepen-
dent of pheromone pathway activation at the restrictive tem-
perature (55). In either case, Gpa1 polyubiquitination is highest
in cells arrested inG1 phase. Taken together, the data presented
here reveal that Gpa1 is dynamically regulated. Phosphoryla-
tion and ubiquitination are independent of the pheromone
stimulus and therefore not the result of feedback regulation.
Rather, these modifications occur in conjunction with the cell
cycle. Thus, the G protein is simultaneously a regulator of, and
regulated by, cell cycle progression.
DISCUSSION
It is nowwell established that theGprotein subunitGpa1 is
ubiquitinated.Herewehave begun to discern how this ubiquiti-
nation event is regulated. Our investigation began by showing
that Gpa1 is phosphorylated and that phosphorylation results
in an electrophoreticmobility shift of the protein. This property
allowed us to determine that a single kinase (Elm1) is necessary
for proper phosphorylation in vivo. Using purified components,
we showed that Elm1 is also sufficient for Gpa1 phosphoryla-
tion in vitro. Elm1 is expressed primarily in S and G2/M phases
of the cell cycle. Correspondingly, we found that the G protein
is phosphorylated in a cell cycle-dependent manner. Gpa1 is
polyubiquitinated by SCF, and phosphorylation is typically
required for SCF-mediated ubiquitination. Thus, we investi-
gated whether phosphorylation leads to ubiquitination of Gpa1
and whether ubiquitination also occurs in a cell cycle-depen-
dent manner. Indeed, although Gpa1 phosphorylation peaks in
G2/M phase, ubiquitination occurs in the subsequent G1 phase.
These findings establish that G proteins can be regulated by
progression through the cell cycle. More broadly, they raise the
possibility that other pathway components may also be subject
to cell cycle regulation.
The participation of Elm1 in G protein signaling was unex-
pected. Elm1 is best known as a protein kinase that coordinates
events leading to cell division, including bud emergence, mito-
sis, and cytokinesis (33, 39–43). In this capacity, Elm1 phos-
FIGURE 5. Elm1 is required for Gpa1 polyubiquitination. Temperature-sen-
sitive proteasome-deficient (cim3-1 or cim3-1/elm1) or isogenic wild-type
cells overexpressing the indicated form of plasmid-borne GPA1 (pAD4M-
GPA1, GPA1) grown at the restrictive temperature. A, accumulation of Gpa1
polyubiquitination in cim3-1 versus cim3-1/elm1. B, accumulation of Gpa1
polyubiquitination in cim3-1 or cim3-1/elm1 cells with or without plasmid
expression of ELM1 or elm1K117R.
FIGURE 6. Gpa1 polyubiquitination by SCFCdc4 is cell cycle-regulated.
Gpa1 phosphorylation in SCF mutant strains or Gpa1 polyubiquitination
under different cell cycle arrested conditions. A, accumulation of phosphory-
lated Gpa1 (p-Gpa1) in cells lacking functional SCFCdc4. Gpa1 immunoblot
analysis of whole cell extracts from temperature-sensitive cdc4-1 or cdc34-2
mutant strains, or the isogenic wild-type strain. The bar graph represents the
ratio of phosphorylated Gpa1 (top band) to the sum total of Gpa1 (top and
bottom bands) expressed as a percentage (left panel). Shown is the same anal-
ysis conducted for Gpa1 from asynchronous (AC) or nocodazole-arrested (NZ)
wild-type cells (right panel). Results are the mean  S.E. for three independent
experiments analyzed in triplicate. B, accumulation of Gpa1 polyubiquitina-
tion (from plasmid pAD4M, top panel) or total Myc-ubiquitin (bottom panel) in
wild type BY4741 cells harboring copper-inducible myc-ubiquitin and
arrested in G1 phase with -factor (-F), in S phase with hydroxyurea (HU), or
in G2/M phase with nocodazole (NZ), followed by CuSO4 induction of Myc-
ubiquitin. C, quantitation of absolute immunoblot intensity for ubiquitinated
Gpa1 and Myc-ubiquitin (Myc-Ub) from B. Results are the mean  S.E. for three
independent experiments analyzed in triplicate.
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phorylates protein kinases involved in septin organization and
cytokinesis (Gin4 and Cla4) (33, 39, 42), another kinase that
phosphorylates and deactivates the morphogenesis checkpoint
protein Swe1 (Hsl1) (40, 41), and a fourth kinase that inhibits
the mitotic exit network when the spindle position checkpoint
is activated (Kin4) (56). It is unlikely that Gpa1 is regulated by
any of these Elm1 substrates, given that deletion of those genes
has no effect on Gpa1 phosphorylation or pheromone respon-
siveness. Thus, Gpa1 represents a new target of Elm1.
Whereas elm1 was the only mutant that exhibited a loss of
Gpa1 phosphorylation, some residual phosphorylation could
still be detected in vivo (Fig. 2A). Therefore, we speculate that
Gpa1 is phosphorylated by another kinase. Possibilities include
kinases that are absent from the gene deletion array, kinases
essential for cell viability, and kinases that have functions
related to Elm1. Elm1 is one of three closely related kinases,
including Tos3 and Sak1. All three proteins are known to phos-
phorylate and activate Snf1 (the yeast homolog of human
AMPK (5 AMP-activated protein kinase), primarily under
conditions of glucose starvation (57). Under the normal growth
conditions used to assess mating pheromone responses how-
ever, deletion ofTOS3, SAK1, or SNF1 does not appear to affect
Gpa1 phosphorylation or pheromone signaling (supplemental
Fig. 1A). Taken together, our findings indicate that Elm1 is
largely responsible for Gpa1 phosphorylation, is uniquely able
to regulate the pheromone response pathway, and does so in a
cell cycle-dependent manner.
Other lines of evidence support the model that Elm1 phos-
phorylates Gpa1. First, Gpa1 is neither phosphorylated nor
ubiquitinated when Elm1 is absent. In contrast, we did not
observe any such differences in the absence of 108 other
kinases. Second, we did not observe any differences in the
absence of 31 different protein phosphatases. Thus it is unlikely
that Elm1 acts indirectly by inhibiting the function of a Gpa1-
phosphatase. Third, we detected a substantial accumulation of
phosphorylated Gpa1 in the absence of the SCF function.
Finally, we detected a substantial enrichment of Gpa1 poly-
ubiquitination in G1-arrested cells as compared with S or
G2/M-arrested cell cultures. These data confirm that phosphor-
ylation and ubiquitination occur in a cell cycle-dependentman-
ner and that phosphorylation precedes ubiquitination.
As the primary negative regulator of the mating pathway,
Gpa1 is a logical target for regulation by posttranslational mod-
ifications. We have shown that pheromone-dependent gene
transcription is diminished in cells that lack Elm1 function.
Similarly, pheromone-dependent gene transcription is dimin-
ished in cells expressing Gpa1UD. Gpa1UD lacks a domain
(UD, residues 129–236) that is required for ubiquitination by
SCF as well as phosphorylation by Elm1 (4, 21, 22). The Gpa1
ubiquitination domain cannot be the only target of phosphory-
lation, however, because mutation of all 15 serine and threo-
nine residues within this region failed to diminish phosphory-
lation in vitro (data not shown) or ubiquitination in vivo
(supplemental Fig. 4). Thus, alternate phosphorylation sites are
likely to exist, and these may likewise target the protein for
polyubiquitination, at least under some circumstances. Taken
together, these data indicate that phosphorylation can occur at
multiple sites throughout the protein, whereas ubiquitination is
restricted to a specific subdomain of the protein.
We have now identified the primary components necessary
for Gpa1 phosphorylation (Elm1) and polyubiquitination
(SCF). While much has been learned, substantive questions
remain. For instance, we have yet to establish how Elm1 and
SCFwork together tomodulate G protein function. All existing
data indicate redundancywithin this process because perturba-
tions to phosphorylation or ubiquitination have modest effects
on G protein stability. Selective pressure in yeast may have
instilled this property because cells lacking Gpa1 cannot grow
as a result of G1 cell cycle arrest. Alternatively phosphorylation
and ubiquitinationmay affectGprotein signaling in otherways.
For example, ubiquitination could affect G protein catalytic
activity. Ubiquitination could also serve to restrict Gpa1 local-
ization to specific signal transduction complexes. Considering
that Elm1 is localized predominately to the bud neck between
dividing cells, Gpa1 phosphorylation and subsequent polyubiq-
uitination may occur only during cell division or within a spe-
cialized subdomain of the plasma membrane (Fig. 7). Indeed,
FIGURE 7. Model of cell cycle G protein regulation. Elm1 phosphorylates a subpopulation of Gpa1 during S and G2/M phase. Phosphorylated Gpa1 is stable
until entrance into the following G1 phase, when it is targeted for polyubiquitination by the SCF
Cdc4 ubiquitin ligase. The selective mechanism responsible for
initiating phosphorylation of a fraction of the total G protein population is unknown (?) but may be due to cellular localization of signal transduction complexes
near the bud neck of a dividing cell where Elm1 is localized during the S and G2/M phases. Localization-specific cell cycle-dependent ubiquitination of Gpa1
may provide a mechanism to optimize the local stoichiometry of G relative to G subunits and restrict signaling competency to G1 phase of the cell cycle.
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Gpa1was recently shown to concentrate to the bud neck during
G2/M phase, where Elm1 is located (58).
The yeast mating response is perhaps the best-characterized
of any signal transduction system, yet it continues to reveal new
mechanisms of signal regulation. It has long been known that
pheromone stimulation activates the G protein and promotes
cell cycle arrest inG1.We now find that theG protein subunit
is phosphorylated and ubiquitinated in amanner that is contin-
gent on cell cycle progression. The abundance of phosphory-
lated Gpa1 increases as cells progress through the S and G2/M
phases and decreases rapidly after cells divide and enter G1
phase. Taken together, these data show that the G protein can
be dynamically regulated. More broadly, these findings reveal a
previously unsuspected degree of coordination between G pro-
tein signaling and cell division.
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